Azienda Sanitaria Locale Avezzano Sulmona L'Aquila

Clinical research at Azienda Sanitaria Locale Avezzano Sulmona L'Aquila includes a strong focus on cardiovascular diseases, especially hypertension, heart failure, and broader atherosclerotic cardiovascular disease. These studies are designed to evaluate new treatment options and better understand how to reduce major cardiovascular events and improve long-term outcomes.

• High blood pressure, uncontrolled and resistant hypertension
• Established cardiovascular disease and high cardiovascular risk
• Heart failure and cardiovascular event prevention

The site is also involved in trials that assess whether emerging therapies can improve blood pressure control and lower the risk of serious complications in people with cardiometabolic disease.

A major part of the research portfolio at the Department of Biotechnological and Clinical Sciences, University of L’Aquila centers on immune-mediated diseases, with studies in atopic dermatitis, hidradenitis suppurativa, prurigo nodularis, psoriasis, and vitiligo. The trials are mainly aimed at testing new therapies and improving symptom control for chronic inflammatory skin conditions.

• Atopic dermatitis and long-term disease control
• Hidradenitis suppurativa and treatment response
• Prurigo nodularis, psoriasis, and vitiligo

These studies explore whether newer treatments can reduce itching, skin lesions, and flare-ups while offering better safety and durability of benefit for patients living with persistent dermatologic immune disorders.

The site also contributes to research in nervous system diseases, particularly migraine and related headache disorders. Trials here are focused on both prevention and acute treatment, with the goal of improving headache control, reducing attack frequency, and easing the burden of chronic symptoms.

• Chronic migraine and episodic migraine
• Menstrual migraine and medication overuse headache
• Acute and preventive headache treatment strategies

This area of research is important for patients whose headaches interfere with daily life, and it reflects an ongoing effort to evaluate more effective options for migraine management.

Another active field at this Italian research site is nutritional and metabolic disease research, including studies in obesity, type 2 diabetes, and chronic kidney disease. These trials aim to improve disease control and examine whether new therapies can lower metabolic and kidney-related risks over time.

• Obesity and overweight with cardiovascular risk
• Type 2 diabetes with cardiovascular and kidney complications
• Chronic kidney disease and albuminuria reduction

The research is especially relevant for patients with overlapping cardiometabolic conditions, where the goal is to improve overall health outcomes rather than treat a single condition in isolation.

The trial portfolio includes work in neoplasms, with attention to advanced prostate cancer. These studies are focused on comparing treatment effectiveness and identifying better options for patients with difficult-to-treat disease.

• Metastatic castration-resistant prostate cancer
• Treatment comparison in advanced cancer care
• Improving outcomes for patients with limited options

This cancer research supports efforts to find more effective therapies for people living with advanced malignancies and to improve the quality of treatment decisions in oncology.

Research in skin and connective tissue diseases overlaps strongly with the immune-focused program and includes studies in atopic dermatitis, psoriasis, hidradenitis suppurativa, prurigo nodularis, and vitiligo. These trials are designed to assess symptom relief, skin improvement, and longer-term safety of treatment approaches.

• Chronic inflammatory skin disorders
• Severe plaque psoriasis and body-weight-related treatment needs
• Vitiligo and pigment-related skin disease

Overall, this area highlights a broad effort to test therapies that may offer better disease control for people with persistent dermatologic conditions.

Some studies at Ospedale Regionale San Salvatore address mixed or broader clinical questions that do not fit neatly into one therapeutic category. These trials often focus on evaluating overall treatment benefit and safety in patients with multiple risk factors or overlapping conditions.

• Combined cardiovascular and metabolic risk
• Long-term treatment safety and tolerability
• Evaluation of new therapies across chronic diseases

This reflects a diverse clinical research environment where investigators are studying both disease-specific and cross-cutting approaches to improve patient care.